Annual Operating Profit
-$599.44 M
-$131.01 M-27.97%
December 31, 2023
Summary
- As of February 7, 2025, BBIO annual operating income is -$599.44 million, with the most recent change of -$131.01 million (-27.97%) on December 31, 2023.
- During the last 3 years, BBIO annual operating profit has fallen by -$124.96 million (-26.34%).
- BBIO annual operating profit is now -1266.78% below its all-time high of -$43.86 million, reached on December 31, 2017.
Performance
BBIO Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$187.13 M
-$14.48 M-8.39%
September 30, 2024
Summary
- As of February 7, 2025, BBIO quarterly operating income is -$187.13 million, with the most recent change of -$14.48 million (-8.39%) on September 30, 2024.
- Over the past year, BBIO quarterly operating profit has dropped by -$10.47 million (-5.92%).
- BBIO quarterly operating profit is now -5099.44% below its all-time high of $3.74 million, reached on March 31, 2024.
Performance
BBIO Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$532.70 M
-$29.71 M-5.91%
September 30, 2024
Summary
- As of February 7, 2025, BBIO TTM operating income is -$532.70 million, with the most recent change of -$29.71 million (-5.91%) on September 30, 2024.
- Over the past year, BBIO TTM operating profit has increased by +$66.75 million (+11.13%).
- BBIO TTM operating profit is now -1173.23% below its all-time high of -$41.84 million, reached on March 31, 2018.
Performance
BBIO TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
BBIO Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -28.0% | -5.9% | +11.1% |
| 3 y3 years | -26.3% | -5.9% | +11.1% |
| 5 y5 years | -226.4% | -5.9% | +11.1% |
BBIO Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -28.0% | at low | -5099.4% | at low | -21.0% | +11.1% |
| 5 y | 5-year | -125.2% | at low | -5099.4% | at low | -100.1% | +11.1% |
| alltime | all time | -1266.8% | at low | -5099.4% | at low | -1173.2% | +11.1% |
BridgeBio Pharma Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$187.13 M(+8.4%) | -$532.70 M(+5.9%) |
| Jun 2024 | - | -$172.65 M(-4712.6%) | -$502.99 M(+6.4%) |
| Mar 2024 | - | $3.74 M(-102.1%) | -$472.91 M(-21.1%) |
| Dec 2023 | -$599.44 M(+28.0%) | -$176.66 M(+12.2%) | -$599.44 M(+10.1%) |
| Sep 2023 | - | -$157.42 M(+10.4%) | -$544.32 M(+6.5%) |
| Jun 2023 | - | -$142.57 M(+16.1%) | -$511.00 M(+16.1%) |
| Mar 2023 | - | -$122.79 M(+1.0%) | -$440.21 M(-6.0%) |
| Dec 2022 | -$468.44 M(-18.8%) | -$121.54 M(-2.1%) | -$468.44 M(-8.6%) |
| Sep 2022 | - | -$124.10 M(+72.9%) | -$512.51 M(-4.7%) |
| Jun 2022 | - | -$71.78 M(-52.5%) | -$537.91 M(-4.0%) |
| Mar 2022 | - | -$151.02 M(-8.8%) | -$560.14 M(-2.9%) |
| Dec 2021 | -$576.63 M | -$165.61 M(+10.8%) | -$576.63 M(+7.1%) |
| Sep 2021 | - | -$149.50 M(+59.0%) | -$538.51 M(+5.8%) |
| Jun 2021 | - | -$94.02 M(-43.9%) | -$508.95 M(-5.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2021 | - | -$167.50 M(+31.4%) | -$539.50 M(+13.7%) |
| Dec 2020 | -$474.48 M(+78.2%) | -$127.49 M(+6.3%) | -$474.48 M(+11.5%) |
| Sep 2020 | - | -$119.94 M(-3.7%) | -$425.63 M(+18.2%) |
| Jun 2020 | - | -$124.57 M(+21.5%) | -$360.22 M(+18.1%) |
| Mar 2020 | - | -$102.49 M(+30.3%) | -$304.98 M(+14.5%) |
| Dec 2019 | -$266.24 M(+45.0%) | -$78.64 M(+44.2%) | -$266.24 M(+5.2%) |
| Sep 2019 | - | -$54.53 M(-21.3%) | -$253.19 M(+5.4%) |
| Jun 2019 | - | -$69.32 M(+8.7%) | -$240.11 M(+16.8%) |
| Mar 2019 | - | -$63.75 M(-2.8%) | -$205.57 M(+11.9%) |
| Dec 2018 | -$183.66 M(+318.8%) | -$65.58 M(+58.2%) | -$183.66 M(+55.5%) |
| Sep 2018 | - | -$41.46 M(+19.2%) | -$118.08 M(+54.1%) |
| Jun 2018 | - | -$34.78 M(-16.9%) | -$76.62 M(+83.1%) |
| Mar 2018 | - | -$41.84 M | -$41.84 M |
| Dec 2017 | -$43.86 M | - | - |
FAQ
- What is BridgeBio Pharma annual operating income?
- What is the all time high annual operating profit for BridgeBio Pharma?
- What is BridgeBio Pharma annual operating profit year-on-year change?
- What is BridgeBio Pharma quarterly operating income?
- What is the all time high quarterly operating profit for BridgeBio Pharma?
- What is BridgeBio Pharma quarterly operating profit year-on-year change?
- What is BridgeBio Pharma TTM operating income?
- What is the all time high TTM operating profit for BridgeBio Pharma?
- What is BridgeBio Pharma TTM operating profit year-on-year change?
What is BridgeBio Pharma annual operating income?
The current annual operating profit of BBIO is -$599.44 M
What is the all time high annual operating profit for BridgeBio Pharma?
BridgeBio Pharma all-time high annual operating income is -$43.86 M
What is BridgeBio Pharma annual operating profit year-on-year change?
Over the past year, BBIO annual operating income has changed by -$131.01 M (-27.97%)
What is BridgeBio Pharma quarterly operating income?
The current quarterly operating profit of BBIO is -$187.13 M
What is the all time high quarterly operating profit for BridgeBio Pharma?
BridgeBio Pharma all-time high quarterly operating income is $3.74 M
What is BridgeBio Pharma quarterly operating profit year-on-year change?
Over the past year, BBIO quarterly operating income has changed by -$10.47 M (-5.92%)
What is BridgeBio Pharma TTM operating income?
The current TTM operating profit of BBIO is -$532.70 M
What is the all time high TTM operating profit for BridgeBio Pharma?
BridgeBio Pharma all-time high TTM operating income is -$41.84 M
What is BridgeBio Pharma TTM operating profit year-on-year change?
Over the past year, BBIO TTM operating income has changed by +$66.75 M (+11.13%)